Interdisciplinary Conference on
Exclusive 1-day symposium for Dutch healthcare professionals
TBD (24-26?) September 2020 | Haarlem, The Netherlands
An international symposium featuring many of the world’s leading experts in psychedelic research and therapy.
Psychiatrists, GZ psychologists, psychotherapists, clinical psychologists, addiction doctors, and other BIG-registered professionals in the Netherlands.
Thursday 24 OR Friday 25 September
09:30 – 18:00
There is a growing body of evidence suggesting that psychedelics can be used safely and effectively to treat mental disorders, including depression, PTSD, and substance use disorders.
During this one-day symposium, leading psychiatrists, psychotherapists, neuroscientists, and psychopharmacologists in the field of psychedelic-assisted therapies will share the latest scientific developments and insights into the therapeutic use of psychedelics, and discuss the future of treatment and research with MDMA, psilocybin, LSD and other compounds.
This state-of-the-art symposium will showcase the latest clinical evidence on psychedelics in the treatment of mental disorders and will facilitate in-depth interaction and discussion.
Prof. dr. Eric Vermetten (LUMC)
Prof. dr. Robert Schoevers (UMCG)
Dr. Metten Somers (UMC Utrecht)
Prof. dr. Wim van den Brink (AUMC).
VVGN (Dutch Association for Addiction Medicine) 6 points
KNMG (Royal Dutch Medical Association) 6 points
FGzPt (Dutch Federation of Healthcare Psychologists and Psychotherapists) 9 points
NVvP (Dutch Association for Psychiatry) 6 points
This is a separate symposium aimed to inform and educate healthcare professionals in the Netherlands. You will need a BIG registration number to register. Attendees of ICPR 2020 don’t need to worry, as all speakers will also present during the three days of ICPR 2020.
A limited amount of tickets is available. Price is €295.
For a surplus of €150, attendees can also attend Saturday and Sunday of the Interdisciplinary Conference on Psychedelic Research. A few discounted tickets are available for AIOs, resident psychiatrists in GZ-psychologists in training, at €175.
CONFIRMED ISPPP SPEAKERS
Some of the questions that will be discussed at ISPPP
- What skills, competencies and knowledge do therapists need and how do we train them?
- What do we know about the neuro-biological and psychological working mechanisms of these substances?
- What is the role of treatment context, music, and integration sessions in establishing (long-term) clinical outcomes?
- Can psychedelic-assisted treatments be integrated into conventional mental health care infrastructures?
- Can we apply conventional psycho-therapeutic methods to psychedelic-assisted therapies or are novel methods needed?
Overview of working mechanisms & research
09:40 AM – 10:05 AM
10:05 AM – 10:30 AM
Clinical applications of MDMA
10:30 AM – 10:50 AM
10:50 AM – 11:05 AM
11:05 AM – 11:20 AM
Clinical applications of psilocybin
11:50 AM – 12:05 PM
12:05 – 12:20
12:20 – 12:50
Psychedelic-assisted psychotherapy: clinical experience and observations
14:20 – 14:40
14:40 – 15:00
15:00 – 15:50
Working mechanisms and setting
16:20 – 16:35
16:35 – 16:50
16:50 – 17:05
17:05 – 17:20
17:30 – 18:15